THE TASK FORCE FOR GLOBAL HEALTH INC: Form 990, tax year 2020

View the entire original 990 at ProPublica ↗

Organization: THE TASK FORCE FOR GLOBAL HEALTH INC (EIN 58-1698648)
Tax period: 2020-09-01 to 2021-08-31
Filed: 2022-06-13
IRS object ID: 202211649349301271
Schema version: 2020v4.0
Source: Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header
Form 990
Schedule A
Schedule B
Schedule C
Schedule D
Schedule F
Schedule I
Schedule J
Schedule K
Schedule O
Schedule R
Reasonable Cause Explanation

Return header ReturnHeader

Field	Value	IRS element (for citing)
Return	2022-06-13T14:12:16-07:00	ReturnTs
Tax Period End	2021-08-31	TaxPeriodEndDt
Return Type	990	ReturnTypeCd
Tax Period Begin	2020-09-01	TaxPeriodBeginDt

Filer Filer

Field	Value	IRS element (for citing)
EIN	581698648	EIN

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	THE TASK FORCE FOR GLOBAL HEALTH INC	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Business Name Control	TASK	BusinessNameControlTxt
Phone	4045921430	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	330 W Ponce de Leon Ave	AddressLine1Txt
City	Decatur	CityNm
State Abbreviation	GA	StateAbbreviationCd
ZIP	300303001	ZIPCd

Business Officer BusinessOfficerGrp

Field	Value	IRS element (for citing)
Person	William Nichols	PersonNm
Person Title	Chief Operating Officer	PersonTitleTxt
Phone	4045921430	PhoneNum
Signature	2022-05-02	SignatureDt

Additional Filer Information AdditionalFilerInformation

Trusted Customer TrustedCustomerGrp

Field	Value	IRS element (for citing)
Trusted Customer	1	TrustedCustomerCd
OOB Security Verification	11	OOBSecurityVerificationCd
Last Submission Rqr OOB	1	LastSubmissionRqrOOBCd
Authentication Assurance Level	AAL2	AuthenticationAssuranceLevelCd

Field	Value	IRS element (for citing)
Tax	2020	TaxYr
Build TS	2022-09-23 18:48:47Z	BuildTS

Form 990 IRS990

Field	Value	IRS element (for citing)
Principal Officer	William Nichols	PrincipalOfficerNm

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	330 W Ponce de Leon Ave	AddressLine1Txt
City	Decatur	CityNm
State Abbreviation	GA	StateAbbreviationCd
ZIP	30030	ZIPCd

Field	Value	IRS element (for citing)
Gross Receipts	$83,832,721	GrossReceiptsAmt
Group Return For Affiliates	0	GroupReturnForAffiliatesInd
Organization501c3	Yes (X)	Organization501c3Ind
Website Address	www.taskforce.org	WebsiteAddressTxt
Type Of Organization Corp	Yes (X)	TypeOfOrganizationCorpInd
Formation	1986	FormationYr
Legal Domicile State	GA	LegalDomicileStateCd
Activity Or Mission	The mission of The Task Force for Global Health is to solve large-scale health problems affecting populations through three impact areas: health system strengthening, center for vaccine equity, and neglected tropical diseases. These impact areas include programs such as pandemic preparedness, polio eradication, field epidemiology training, public health informatics, health workforce development, and medical surplus recovery.	ActivityOrMissionDesc
Voting Members Governing Body	10	VotingMembersGoverningBodyCnt
Voting Members Independent	9	VotingMembersIndependentCnt
Total Employee	227	TotalEmployeeCnt
Total Volunteers	17	TotalVolunteersCnt
Total Gross UBI	$0	TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm	$0	NetUnrelatedBusTxblIncmAmt
PY Contributions Grants	$58,766,564	PYContributionsGrantsAmt
CY Contributions Grants	$82,102,252	CYContributionsGrantsAmt
PY Program Service Revenue	$0	PYProgramServiceRevenueAmt
CY Program Service Revenue	$0	CYProgramServiceRevenueAmt
PY Investment Income	$639,010	PYInvestmentIncomeAmt
CY Investment Income	$896,779	CYInvestmentIncomeAmt
PY Other Revenue	-$512,427	PYOtherRevenueAmt
CY Other Revenue	-$1,345,174	CYOtherRevenueAmt
PY Total Revenue	$58,893,147	PYTotalRevenueAmt
CY Total Revenue	$81,653,857	CYTotalRevenueAmt
PY Grants And Similar Paid	$7,372,160	PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid	$11,498,310	CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members	$0	PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members	$0	CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid	$20,560,913	PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid	$24,026,550	CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns	$0	PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns	$0	CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense	$21,649	CYTotalFundraisingExpenseAmt
PY Other Expenses	$31,889,462	PYOtherExpensesAmt
CY Other Expenses	$39,050,751	CYOtherExpensesAmt
PY Total Expenses	$59,822,535	PYTotalExpensesAmt
CY Total Expenses	$74,575,611	CYTotalExpensesAmt
PY Revenues Less Expenses	-$929,388	PYRevenuesLessExpensesAmt
CY Revenues Less Expenses	$7,078,246	CYRevenuesLessExpensesAmt
Total Assets BOY	$67,961,569	TotalAssetsBOYAmt
Total Assets EOY	$76,441,049	TotalAssetsEOYAmt
Total Liabilities BOY	$15,364,889	TotalLiabilitiesBOYAmt
Total Liabilities EOY	$16,766,123	TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY	$52,596,680	NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY	$59,674,926	NetAssetsOrFundBalancesEOYAmt
Mission	The mission of The Task Force for Global Health is to solve large-scale health problems affecting populations through three impact areas: health system strengthening, center for vaccine equity, and neglected tropical diseases. These impact areas include programs such as pandemic preparedness, polio eradication, field epidemiology training, public health informatics, health workforce development, and medical surplus recovery.	MissionDesc
Significant New Program Srvc	0	SignificantNewProgramSrvcInd
Significant Change	0	SignificantChangeInd
Expense	$27,215,053	ExpenseAmt
Grant	$1,410,446	GrantAmt
Revenue	$27,215,053	RevenueAmt
Desc	TEPHINET awarded more than $380,000 in Emergency Capacity Building Grants to 19 FETPs to support activities to strengthen their COVID-19 response capacities. We also provided support to FETPs to assist with training, surveillance and epidemiologic investigations in Central America, Colombia, Ecuador, Haiti, Pakistan, Ukraine, Vietnam, and Yemen. From August 2020 to August 2021, the program helped train more than 140 epidemiologists from 40 countries in public health emergency response in collaboration with CDC and GOARN. In addition, it began developing emergency response training for FETP alumni in partnership with CDC, PAHO, the Colombian Red Cross, and the Harvard Humanitarian Initiative. Four different types of small grants were offered to individual FETP trainees and graduates to enable field projects contributing to infectious and non-infectious disease prevention and control. The Program launched its 6th cycle of FETP accreditation with a new option for programs to be accredited at a higher standard than previously possible and in addition, it conducted 3 workshops at regional FETP conferences. TEPHINET co-hosted 3 virtual events connecting more than 1,400 public health professionals worldwide. Featuring more than 150+ oral and poster presentations and 30+ interactive learning and keynote sessions, the 11th TEPHINET Regional Scientific Conference of the Americas, 10th Southeast Asia and Western Pacific Bi-regional TEPHINET Scientific Conference, and FETP International Nights provided dozens of FETP trainees and alumni with opportunities to share their work with wider audiences, and build knowledge and skills in topics ranging from COVID-19 response to scientific writing, mental health, and program evaluation. In March, the Program launched the Field Epidemiology Abstract Database (FEAD), making more than 1,100 abstracts presented during our conferences available to the public. It also launched 8 free e-learning and classroom resources on the TEPHINET Learning Center. In partnership with the International Society for Infectious Diseases, it developed a special supplement to the International Journal of Infectious Diseases. "Field Epidemiology: The Complex Science behind Battling Acute Health Threats" featuring 11 articles highlighting investigations conducted by FETP trainees and graduates around the world. On September 7, TEPHINET led the global celebration of the first World Field Epidemiology Day, reaching more than 28 million people on social media and leading to more than a dozen events around the world. More than 40 organizations joined us as official partners. TEPHINET advocated for global field epidemiology capacity building and investment in FETPs through participation in meetings led by the World Health Organization, United Nations, European Union, Pandemic Action Network, and Global Health Council. It also testified on this topic before the U.S. Congress. TEPHINET officially assumed its role as the secretariat to the FETP Enterprise Strategic Leadership Group (SLG), which was formed to provide high-level leadership and accountability for the Global Field Epidemiology Roadmap. The SLG and its associated working groups have been meeting throughout 2021 to develop implementation plans for the Roadmap's recommendations. Through cooperative agreements with our funding partners, CDC and the U.S. Department of State, TEPHINET implemented over 130 projects worldwide aimed at strengthening health systems, improving disease surveillance and response, and increasing public health workforce capacity in field epidemiology. Public Health Informatics Institute (PHII) provided direct services to the U.S. public health system through a cooperative agreement with the Centers for Disease Control (CDC) and funding from the Robert Wood Johnson foundation. This funding supported PHII and its partners in efforts to increase the capacity of public health informaticians and other public health leaders and practitioners to improve the collection, management and use of information and information technology for protecting and improving health and reducing disparities. Key activities included providing workforce development and online tools to state and local health departments on the subject of prioritizing and initiating ongoing data modernization efforts; providing training to public health professionals in essential informatics competencies; carrying out a national assessment of the health IT and informatics landscape supporting self-measured blood pressure monitoring to identify gaps and barriers for widespread adoption and make recommendations for successful nationwide adoption; and equipping pilot sites across the United States to commence data collection on opioid use disorder in pregnant women. Additionally, PHII is an ongoing partner on a collaborative Gates Foundation-funded project that is collecting data to reduce childhood mortality across the globe; this project is working on mortality surveillance activities at sites in Asia and Sub Saharan Africa. PHII is also engaged with USAID funding for ongoing support of the creation and launch of a new, modernized database for tracking neglected tropical diseases; this year, these efforts included technical assistance for the development of core functional applications and convening a working forum for requirements development across key partners. The existence of this database will unify and standardize tracking and data analysis efforts that are part of the global, inter-organizational campaign to eliminate and eradicate neglected tropical diseases. Health Campaign Effectiveness(HCE) The first HCE Coalition meeting was held virtually on October 20-21, 2020. Over 180 people from 26 countries registered and 118 participated in the discussion groups. Members shared lessons learned on restarting campaigns during COVID-19, opportunities for collaboration and integrating campaigns, and transitioning from campaigns to PHC service delivery. HCE initiated a series of learning and knowledge exchange activities and events aimed to accelerate the identification of emerging lessons and promising practices around campaign integration and transitioning campaigns into PHC. These include hosting four "test and learn" webinars, several awardee exchanges, monthly newsletters, expanding the resources on the campaigneffectiveness.org website, and creating a web-based platform for collaboration among research awardees. New information and lessons learned emerged from a five-country study of opportunities for campaign integration (by BRI); a two-country study on community factors shaping campaign effectiveness (by Design Institute for Health (DIH)), a study of campaign outcome measures beyond coverage (UNICEF) and a study of campaign costs and efficiencies (by Thinkwell). Two project teams from Nigeria shared their lessons learned on collaborative campaign planning for malaria and immunizations in a highly attended webinar. Two additional technical briefs were developed: one on integration of Neglected Infectious Diseases in the Latin American and Caribbean Region (authored in collaboration with PAHO) and one on campaign integration--Lessons Learned from 30 years of polio (authored by STRIPE/Johns Hopkins University). The Scientific and Technical Advisory Committee (STAC) met four times, developed the HCE Research and Learning Agenda (RLA), provided input into a request for proposals (RFP) for implementation research, advised on the selection of research awards, and continues to support the on-going identification and promotion of promising practices. The Campaign Integration Working Group (CIWG) also met four times, contributed to the RLA and selection of implementation research awards, developed and promoted the campaign integration decision tool and has voiced their commitment to expanding their scope to develop new tools and resources in 2022. Together these governance groups include 51 members from 33 organizations and over a dozen countries. Obligating funds for implementation/operational research (i.e. sub-awards) was a high priority for year 2. Using carry-over funds from year one, the budget from implementation research was increased from the initial allocation of $2.2 million to approximately $2.9 million. MedSurplus Alliance (MSA) provided over $183,000,000 in life-saving medical supplies, equipment, and medications to low-income communities through 1,214 qualified partners in 57 countries throughout the globe. These donations represent more than 4.5 million pounds of excess quality medical supplies repurposed to provide vital care for individuals in need, a significant step towards strengthening healthcare delivery and sustainable practices.	Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

Field	Value	IRS element (for citing)
Expense	$14,188,906	ExpenseAmt
Grant	$3,584,872	GrantAmt
Revenue	$14,188,906	RevenueAmt
Desc	Neglected Tropical Disease Support Center (NTD SC) Funded principally by the Bill & Melinda Gates Foundation, the U.S. Agency for International Development and the United Kingdom AID (UK AID), the NTD SC supports Operational Research (OR) to eliminate neglected tropical diseases that threaten the lives and well-being of more than one billion of people in some of the world's poorest communities. As of 2021, the NTD SC manages a portfolio of more than 250 OR projects spanning 60 countries, and targeting all five neglected tropical diseases amenable to preventive chemotherapy: lymphatic filariasis, onchocerciasis, STH, schistosomiasis and trachoma as well as other NTDs such as podoconiosis, leprosy and leishmaniasis. OR projects are designed to address challenges that prevent programs from achieving disease control and elimination goals and to inform World Health Organization (WHO) recommendations and guidance for NTD programs. With support from USAID in 2021, the NTD-SC for the first time issued calls for proposals to support research focused on the development of new diagnostic tools. In addition, with funding from USAID and UK Aid, the NTD SC continued to support the African Research Network for Neglected Tropical Diseases (ARNTD). ARNTD manages a portfolio of research projects carried out by young African scientists at early stages of their careers. The NTD SC also serves as the Secretariat for the Coalition for Operational Research on Neglected Tropical Diseases (COR NTD). The annual COR-NTD meeting brings together a growing group of researchers and country program implementers working to foster important collaborations to address the challenges faced by NTD programs that prevent the shared goal of eliminating these infections. Due to the travel restrictions imposed by COVID, the annual meeting and other COR-NTD technical meetings have now pivoted to virtual meetings in order to continue communal efforts to translate research outcomes into program practice and new ideas into future OR projects. The International Trachoma Initiative (ITI) works tirelessly for a world free from trachoma, even in the midst of a global pandemic. ITI contributes to the ultimate elimination of trachoma by stewarding Pfizer's donation of Zithromax(R) to treat and prevent the condition; building and strengthening partnerships to accelerate progress; and developing innovative tools to share data. Between September 2020 to August 2021, ITI organized just in time shipments of 47.4 million treatments for trachoma to be distributed at MDAs in 14 countries. As of August 2021, ITI shipped more than 953.2 million treatments to trachoma endemic countries since 1999. ITI continued its data management support for Tropical Data, a free mobile phone-based service to support trachoma programs as they conduct prevalence surveys, providing them with robust data for decision making on where antibiotic treatments are needed and where they can be stopped. As a key player in the global trachoma community, there have been tremendous achievements in reducing the population at risk of blindness from trachoma from an estimated 1.2 billion people in 2000 to 136.2 million in June 2021 according to the World Health Organization's (WHO) Weekly Epidemiological Record (WER). ITI will continue to work smarter so that the dream of a trachoma free world becomes a reality. The Mectizan Donation Program: Although mass treatment with Mectizan was interrupted at the beginning of the pandemic in 2020 from April to September, by 2021 interventions had resumed with COVID19 mitigation measures in place. In 2021, a total of 364.4 million treatments were approved-a decrease from 2020 when 416.8 million treatments were approved. This was due to several factors, most of which are related to the cancellation of ten applications due to the surplus inventory of Mectizan(R) that remained as a result of the lockdown and the interruptions and delays to MDA in 2020. Another factor was the temporary suspension of MDA in two countries where high customs clearance fees prevented shipments of donated Mectizan from reaching the national programs. We invite governments of countries where high clearance fees are assessed on donated medicines to take special measures to eliminate these import charges to avoid lack of access to vital, free medicines. An unexpected challenge arose as misinformation spread about the use of ivermectin as an alleged cure for COVID19 patients. This raised the risk of diversion of the donated Mectizan to unauthorized uses. In a heartening display of resilience, country partners and supporting organizations, the Mectizan Donation Program, the Mectizan Expert Committee, and Merck & Co., Inc. took diligent measures to protect Mectizan for its intended use: elimination of river blindness and LF. We are particularly grateful to our colleagues from the Department of Control of Neglected Tropical Diseases of WHO headquarters and from WHO Afro's Expanded Special Program to Eliminate NTDs (ESPEN) for hosting two webinars to clarify WHO position and sensitize countries on good use of Mectizan donated for the elimination of LF and river blindness. As of the end of 2021, cumulatively, nearly 4.8 billion Mectizan treatments have been approved by the Mectizan Donation Program, and nearly 11 billion tablets have been shipped to endemic countries by Merck since the donation was announced in 1987. These numbers are staggering. Even more staggering is the number of people who no longer need treatment with Mectizan as transmission of the diseases is suspected to have been interrupted. For river blindness, this number is 15.7 million and for LF the number is 191.8 million. It is remarkable to see these numbers increase each year as countries downscale the number of people treated. Five new countries and territories (Comoros, Nepal, Myanmar, French Polynesia and New Caledonia) were approved to receive Mectizan for the implementation of IDA to accelerate elimination of LF, bringing the number of IDA implementing countries and territories to 20. The Global Partnership for Zero Leprosy (GPZL) had many activities during the year. COVID19 Response. GPZL has worked to support the leprosy community during the COVID19 pandemic, forming working groups to address unique challenges faced by the community. Working Group 1 solved pandemic related supply chain problems to ensure that leprosy patients receive the multi drug therapy medication they need. Working Group 2 consulted with persons affected by leprosy to gather and share information about the needs of persons affected during the pandemic. They then offered advice for government and NGO response to these needs. Reports from Working Groups 1 and 2 about their work were published in Leprosy Review in December 2020, and a video created by Working Group 2 about the challenges faced by persons affected during the pandemic, featuring the voices of women affected, was released late November 2020. Country work. GPZL announced 10 new country partners (as well as continued work with Nepal) in 2020 and began country model implementation in Ghana in November, 2020. GPZL cohosted a webinar series on SDR PEP (leprosy post exposure prophylaxis with single dose rifampicin, a new preventative medication for leprosy) implementation with WHO's Global Leprosy Program in December 2020, helping to equip National Leprosy Program Managers to implement this new innovation in the field of leprosy. In 2021, Zero Leprosy Country Model implementation continued to gain momentum. Activities began in Cote d'Ivoire in Q2 2021 with the beginning of their country review. This work culminated in a stakeholders meeting and the development of a zero leprosy roadmap. From Q1 and Q3 2021 GPZL engaged two consultants to assist with validation and further development of the Zero Leprosy Country Model, and to build out an M&E framework for the model. Research. GPZL's Research Agenda was published in Infectious Diseases of Poverty in 2020. The agenda identifies the themes necessary for researchers/donors to pursue in order to reach zero leprosy. GPZL moved forward with the prioritization of these research topics and developed a landscape of ongoing research in 2021. GPZL also convened a Diagnostics working group to create target product profiles (TPP) for a leprosy diagnostic in 2020. Their work continued through 2021 with the completion of two target product profiles for leprosy diagnostics in quarters 2 and 3. Increasing funding for leprosy. In Q2 of 2021, GPZL submitted a proposal for a Swift Grant, a new opportunity supported by the MacArthur Foundation through their Bold Solutions Network. We received this award in Q3 and will use the funds to create an advocacy and leadership development curriculum for patient advocates from stigmatizing NTDs. This proposal was submitted in partnership with two other TFGH programs: NTD-SC (also a Bold Solutions Network member) and FACE.	Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

Field	Value	IRS element (for citing)
Expense	$22,590,830	ExpenseAmt
Grant	$6,502,992	GrantAmt
Revenue	$22,590,830	RevenueAmt
Desc	The Covid-19 Vaccine Implementation Program (CoVIP) had a number of activities during the year. Based on the PIVI model, CoVIP worked with CDC to identify partner countries/implementing partners for this project. It funded 35 countries (Albania, Armenia, Barbados, Belize, Bhutan, Burkina Faso, Cameroon, Cote d'Ivoire, Democratic Republic of Congo, El Salvador, Eswatini, Georgia, Ghana, Guatemala, Haiti, Honduras, Kenya, Laos, Lesotho, Malawi, Mali, Moldova, Mongolia, Namibia, Nigeria, Rwanda, Sierra Leone, South Africa, South Sudan, Trinidad and Tobago, Tunisia, Uganda, Uzbekistan, Vietnam, Zambia) which totaled $4.7M. The funding allowed each partner country to access technical support for vaccination program implementation tailored to their specific needs. CoVIP on-boarded a project manager, a program assistant, director of implementation and seven field epi contractors to support the funding process and technical assistance in countries. The team created to implement this project was assembled quickly and effectively and has provided ongoing support to CDC, country Ministries of Health, global partners and TFGH leadership to advance COVID-19 vaccination program goals. The program worked closely with CDC country offices, ministries of health and local NGOs during the implementation phase of the vaccination programs, providing technical assistance on vaccine delivery, safety, demand and communications, program planning, workforce development, data management and use, program evaluation and NITAG/Policy support. The program director, director of implementation and director projects have been involved in the implementation of the partner countries vaccination programs by reviewing and funding proposals to support the countries and also aligning our field staff to support COVID-19 activities in countries. The Partnership for Influenza Vaccine Introduction (PIVI) carried out the following activities: 541,040 influenza vaccines donated and delivered to 11 countries at the cost of $2,702,240. The 11 countries were: Vietnam, Ukraine, Albania, Armenia, Bhutan, Cote d'Ivoire, Kyrgyzstan, North Macedonia, Moldova, Mongolia, Tajikistan. Sub-awards provided to 11 other countries was $1,177,238. Those countries were: Albania, Armenia, Bhutan, Cote d'Ivoire, Kenya, Kyrgyzstan, Moldova, Mongolia, North Macedonia, Ukraine and EMRO. The Sub-awards were for: increasing cold chain for flu, flu communication activities and materials, vaccine distribution, ancillary benefit project, creating communication materials for flu and COVID, economic burden studies, KAP surveys, cost-effectiveness studies. PIVI completed influenza vaccine economic assessment in Morocco, Kyrgyz Republic and Lao PDR. The Lao PDR cost-effectiveness evaluation was published in a peer-reviewed journal and was presented to the Minister of Health. It also funded and completed a survey of global immunization managers to define challenges to influenza vaccine program sustainability. These data have been used to design communications campaigns and to develop new projects to address challenges with our sister program, Ready2Respond. Furthermore, it developed a information resource package for immunization policy leaders in the North Africa-Middle East region and added Ukraine to the PIVI partnership The Global Funders Consortium for Universal Influenza Vaccine Development (Uvax) Program undertook a number of activities. It convened an annual meeting and produced report of the annual meetings that serve to identify ongoing work in the field, highlight opportunities for investment, identify challenges that threaten to slow progress in the field, and possible solutions to address the challenges. The fourth annual meeting of the Consortium took place in two virtual sessions on October 28 and November 16, 2020 with the following outcomes: (1) common landscape of Consortium member activities and partnerships during the past year; (2) Consensus on continuing key Consortium-fostered activities, including the Influenza Vaccine Roadmap and Product Landscape. In addition, Uvax completed and released the Influenza Vaccine Roadmap - the culmination of 3-years of planning and consultation. This will provide a consensus group or sequenced activities that will accelerate the path to improved influenza vaccines. It participated as a member of the IVR Steering Committee with an ongoing support for development of a Technology Landscape for improved/universal vaccines -A revised version of the Landscape was published in January 2021, and TFGH has monthly calls and receives monthly reports from CIDRAP regarding progress. A new contract to extend the work was completed in September 2021. The Program worked with WHO to develop the plan for creating the Full Value Influenza Vaccines Assessment, which will address the consensus statement from members to develop models to understand the full value of next generation influenza vaccines. Funding for the work was made available through other TFGH influenza programs (PIVI and Ready2Respond), but the results will address Consortium priorities. There was also a re-engagement and expansion of the Industry Engagement Working Group to re-engage industry representatives. The focus of the engagement was to understand the effects of COVID-19 on their planned research and development of influenza vaccines. A standard data collection instrument was developed and 12 industry members were interviewed using a structured interview by the working group and the results was presented at the December 2021 meeting. Finally, new members were added including the Department of Biotechnology (Government of India) and the Institute of Virology (Russia). The Coalition for Global Hepatitis Elimination (CGHE) is the only technical and capacity-building organization solely devoted to hepatitis B and hepatitis C elimination. The Coalition is successfully demonstrated how collaborations in technical assistance, advocacy, and research help global, regional, and national leaders can reach goals for hepatitis elimination. Below is a summary of key program highlights. Virtual learning programs: Over the year, the Coalition created new opportunities for partners to share research findings and field experiences. CGHE launched 21 virtual learning sessions that reached 2,200 registrants from 90 countries. Recorded sessions were viewed 900+ times. One virtual meeting series centered on increasing the number of African countries adopting policies for universal hepatitis B birth dose vaccination of newborns. The Coalition convened 290 stakeholders from 35 countries to share updates on the status of hepatitis B birth dose vaccination and to identify needs for technical assistance. As part of this effort, the Coalition began preparing a toolkit to guide policy development for hepatitis B birth dose vaccination. Other virtual meeting topics included scaling hepatitis testing and linkage to care and translation of hepatitis research into public health practice. Launch of Hepatitis Elimination Tool: Budgeting and financial planning are an essential part of hepatitis elimination planning. In July 2021, in partnership with Massachusetts General Hospital/Harvard Medical School, the Coalition launched the web-based Hep C Elimination Tool to support national programs in budget-based planning. The free tool helps countries estimate the hepatitis C testing and treatment volumes needed for HCV elimination and the associated costs of achieving these goals. National Hepatitis Elimination Profiles: Six National Hepatitis Elimination Profiles were developed for the United States, Canada, Mexico, Brazil, Argentina, and Peru and released on World Hepatitis Day 2021. These profiles brought together local stakeholders to forge a shared understanding of their nation's hepatitis burden, along with the unique strengths and challenges of the hepatitis response. Additional activities included, hosting a virtual side-event at the 2020 United Nations General Assembly on the opportunities and challenges presented by the COVID-19 pandemic for hepatitis elimination, assisting WHO's development of the new global strategy for viral hepatitis elimination, completing a systematic review of 100+ national hepatitis action plans, publishing a multi-country research study on HCV retreatment and honoring 7 Hepatitis Elimination Champions for World Hepatitis Day	Desc

Field	Value	IRS element (for citing)
Total Other Prog Srvc Expense	$0	TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Grant	$0	TotalOtherProgSrvcGrantAmt
Total Other Prog Srvc Revenue	$0	TotalOtherProgSrvcRevenueAmt
Total Program Service Expenses	$63,994,789	TotalProgramServiceExpensesAmt
Described In Section501c3	Yes (1)	DescribedInSection501c3Ind
Schedule B Required	Yes (1)	ScheduleBRequiredInd
Political Campaign Acty	0	PoliticalCampaignActyInd
Lobbying Activities	Yes (1)	LobbyingActivitiesInd
Subject To Proxy Tax	0	SubjectToProxyTaxInd
Donor Advised Fund	0	DonorAdvisedFundInd
Conservation Easements	0	ConservationEasementsInd
Collections Of Art	0	CollectionsOfArtInd
Credit Counseling	0	CreditCounselingInd
Donor Rstr Or Quasi Endowments	0	DonorRstrOrQuasiEndowmentsInd
Report Land Building Equipment	Yes (1)	ReportLandBuildingEquipmentInd
Report Investments Other Sec	0	ReportInvestmentsOtherSecInd
Report Program Related Invst	0	ReportProgramRelatedInvstInd
Report Other Assets	0	ReportOtherAssetsInd
Report Other Liabilities	Yes (1)	ReportOtherLiabilitiesInd
Include FIN48 Footnote	0	IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt	0	IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt	Yes (1)	ConsolidatedAuditFinclStmtInd
School Operating	0	SchoolOperatingInd
Foreign Office	Yes (1)	ForeignOfficeInd
Foreign Activities	Yes (1)	ForeignActivitiesInd
More Than5000 K To Org	Yes (1)	MoreThan5000KToOrgInd
More Than5000 K To Individuals	0	MoreThan5000KToIndividualsInd
Professional Fundraising	0	ProfessionalFundraisingInd
Fundraising Activities	0	FundraisingActivitiesInd
Gaming Activities	0	GamingActivitiesInd
Operate Hospital	0	OperateHospitalInd
Grants To Organizations	Yes (1)	GrantsToOrganizationsInd
Grants To Individuals	0	GrantsToIndividualsInd
Schedule J Required	Yes (1)	ScheduleJRequiredInd
Tax Exempt Bonds	Yes (1)	TaxExemptBondsInd
Invest Tax Exempt Bonds	0	InvestTaxExemptBondsInd
Escrow Account	0	EscrowAccountInd
On Behalf Of Issuer	0	OnBehalfOfIssuerInd
Engaged In Excess Benefit Trans	0	EngagedInExcessBenefitTransInd
PY Excess Benefit Trans	0	PYExcessBenefitTransInd
Loan Outstanding	0	LoanOutstandingInd
Grant To Related Person	0	GrantToRelatedPersonInd
Business Rln With Org Mem	0	BusinessRlnWithOrgMemInd
Business Rln With Fam Mem	0	BusinessRlnWithFamMemInd
Business Rln With35 Ctrl Ent	0	BusinessRlnWith35CtrlEntInd
Deductible Non Cash Contri	0	DeductibleNonCashContriInd
Deductible Art Contribution	0	DeductibleArtContributionInd
Terminate Operations	0	TerminateOperationsInd
Partial Liquidation	0	PartialLiquidationInd
Disregarded Entity	0	DisregardedEntityInd
Related Entity	Yes (1)	RelatedEntityInd
Related Organization Ctrl Ent	0	RelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org	0	TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp	0	ActivitiesConductedPrtshpInd
Schedule O Required	Yes (1)	ScheduleORequiredInd
IRP Document	112	IRPDocumentCnt
IRP Document W2 G	0	IRPDocumentW2GCnt
Employee	227	EmployeeCnt
Employment Tax Returns Filed	Yes (1)	EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit	0	UnrelatedBusIncmOverLimitInd
Foreign Financial Account	Yes (1)	ForeignFinancialAccountInd
Foreign Country	CO	ForeignCountryCd
Foreign Country	ET	ForeignCountryCd
Foreign Country	GT	ForeignCountryCd
Prohibited Tax Shelter Trans	0	ProhibitedTaxShelterTransInd
Taxable Party Notification	0	TaxablePartyNotificationInd
Nondeductible Contributions	0	NondeductibleContributionsInd
Quid Pro Quo Contributions	0	QuidProQuoContributionsInd
Form8282 Property Disposed Of	0	Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct	0	RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct	0	PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services	0	IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt	0	SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc	0	SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VI	Yes (X)	InfoInScheduleOPartVIInd
Governing Body Voting Members	10	GoverningBodyVotingMembersCnt
Independent Voting Member	9	IndependentVotingMemberCnt
Family Or Business Rln	0	FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties	0	DelegationOfMgmtDutiesInd
Change To Org Documents	0	ChangeToOrgDocumentsInd
Material Diversion Or Misuse	0	MaterialDiversionOrMisuseInd
Members Or Stockholders	0	MembersOrStockholdersInd
Election Of Board Members	0	ElectionOfBoardMembersInd
Decisions Subject To Approva	0	DecisionsSubjectToApprovaInd
Minutes Of Governing Body	Yes (1)	MinutesOfGoverningBodyInd
Minutes Of Committees	Yes (1)	MinutesOfCommitteesInd
Officer Mailing Address	0	OfficerMailingAddressInd
Local Chapters	0	LocalChaptersInd
Form990 Provided To Gvrn Body	Yes (1)	Form990ProvidedToGvrnBodyInd
Conflict Of Interest Policy	Yes (1)	ConflictOfInterestPolicyInd
Annual Disclosure Covered Prsn	Yes (1)	AnnualDisclosureCoveredPrsnInd
Regular Monitoring Enfrc	Yes (1)	RegularMonitoringEnfrcInd
Whistleblower Policy	Yes (1)	WhistleblowerPolicyInd
Document Retention Policy	Yes (1)	DocumentRetentionPolicyInd
Compensation Process CEO	Yes (1)	CompensationProcessCEOInd
Compensation Process Other	Yes (1)	CompensationProcessOtherInd
Investment In Joint Venture	0	InvestmentInJointVentureInd
States Where Copy Of Return Is Fld	GA	StatesWhereCopyOfReturnIsFldCd
Own Website	Yes (X)	OwnWebsiteInd
Upon Request	Yes (X)	UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Field	Value	IRS element (for citing)
Person	Daniel N Martins	PersonNm
Phone	4046875620	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	330 W Ponce de Leon Ave	AddressLine1Txt
City	Decatur	CityNm
State Abbreviation	GA	StateAbbreviationCd
ZIP	300303001	ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (25 entries)

TitleTitleTxt	Average Hours Per WeekAverageHoursPerWeekRt	Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt	Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd	OfficerOfficerInd	Reportable Comp From OrgReportableCompFromOrgAmt	Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt	Other CompensationOtherCompensationAmt	Key EmployeeKeyEmployeeInd	Highest Compensated EmployeeHighestCompensatedEmployeeInd	Former Ofcr Director TrusteeFormerOfcrDirectorTrusteeInd
David A Ross
President & CEO	39	1	Yes (X)	Yes (X)	$382,486	$0	$53,111
Mark McKinlay
Program Director	39	1		Yes (X)	$272,907	$0	$55,751
William P Nichols
Exec. VP/COO	39	1		Yes (X)	$291,769	$0	$25,527
Patrick O'Carroll
Program Sector Head	39	1			$286,647	$0	$27,069	Yes (X)
Paul Emerson
Program Director	40	0			$238,908	$0	$67,651		Yes (X)
David G Addis
Program Director	40	0			$248,487	$0	$52,489		Yes (X)
Yao Sodahlon
Program Director	40	0			$231,580	$0	$63,128		Yes (X)
John Ward
Program Director	40	0			$259,316	$0	$21,216		Yes (X)
Carl Reddy
Program Director	40	0			$214,444	$0	$64,153	Yes (X)
Vivian Singletary
Program Director	40	0			$225,131	$0	$45,039		Yes (X)
Kris Sarlas
Program Director	40	0			$197,547	$0	$56,510		Yes (X)
Patrick Lammie
Program Director	40	0			$228,276	$0	$21,546	Yes (X)
Daniel Martins
Chief Financial Officer	39	1		Yes (X)	$154,538	$0	$58,924
Ellen Wild
Director of Business Strategy	39	1.00		Yes (X)	$183,679	$0	$16,624
Heather Brooks
Director of Organizational Effectiveness	39	1			$77,079	$0	$21,004			Yes (X)
Teri Plummer McClure
Board Chair	0	0	Yes (X)		$0	$0	$0
Charles H McTier
Board Member	0	0	Yes (X)		$0	$0	$0
Kent Alexander
Board Member	0	0	Yes (X)		$0	$0	$0
James Jackson
Board Member	0	0	Yes (X)		$0	$0	$0
Deborah Kilpatrick
Board Member	0	0	Yes (X)		$0	$0	$0
Walter Orenstein
Board Member	0	0	Yes (X)		$0	$0	$0
Walter Deriso Jr
Board Member	0	0	Yes (X)		$0	$0	$0
Geeta Manek
Board Member	0	0	Yes (X)		$0	$0	$0
Bushra Sayed-Ganguly
Board Member	0	0	Yes (X)		$0	$0	$0
Paula Lawton Bevington
Board Member	0	0			$0	$0	$0			Yes (X)

Field	Value	IRS element (for citing)
Total Reportable Comp From Org	$3,492,794	TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org	$0	TotReportableCompRltdOrgAmt
Total Other Compensation	$649,742	TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K	49	IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed	Yes (1)	FormerOfcrEmployeesListedInd
Total Comp Greater Than150 K	Yes (1)	TotalCompGreaterThan150KInd
Compensation From Other Srcs	0	CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/ForeignAddress/AddressLine1Txt	CityContractorAddress/ForeignAddress/CityNm	Province Or StateContractorAddress/ForeignAddress/ProvinceOrStateNm	CountryContractorAddress/ForeignAddress/CountryCd	Foreign PostalContractorAddress/ForeignAddress/ForeignPostalCd	ServicesServicesDesc	CompensationCompensationAmt	Address Line1ContractorAddress/USAddress/AddressLine1Txt	CityContractorAddress/USAddress/CityNm	State AbbreviationContractorAddress/USAddress/StateAbbreviationCd	ZIPContractorAddress/USAddress/ZIPCd
Barbara Law
85 Holliday Drive	Whitby	Ontario	CA	L1P 1E7	Healthcare Consulting	$368,700
Camber Collective LLC
					Health Consulting Services	$298,800	2505 2nd Ave Suite 415	Seattle	WA	98121
CMT Consulting LLC
					Consulting services	$202,194	106 Geneva Street	Decatur	GA	30030
HLN Consulting
					Informatic services	$198,797	9 Pemberly	Mission Viejo	CA	92692
Cornelia Dekker
					Health Consulting Services	$162,400	24 Jenna Lane CA 940	Half Moon Bay	CA	94019

Field	Value	IRS element (for citing)
Cntrct Rcvd Greater Than100 K	18	CntrctRcvdGreaterThan100KCnt
Federated Campaigns	$0	FederatedCampaignsAmt
Membership Dues	$0	MembershipDuesAmt
Fundraising	$0	FundraisingAmt
Related Organizations	$0	RelatedOrganizationsAmt
Government Grants	$45,671,316	GovernmentGrantsAmt
All Other Contributions	$36,430,936	AllOtherContributionsAmt
Noncash Contributions	$0	NoncashContributionsAmt
Total Contributions	$82,102,252	TotalContributionsAmt
Total Program Service Revenue	$0	TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$896,779	TotalRevenueColumnAmt
Related Or Exempt Func Income	$896,779	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$0	UnrelatedBusinessRevenueAmt
Exclusion	$0	ExclusionAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt
Related Or Exempt Func Income	$0	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$0	UnrelatedBusinessRevenueAmt
Exclusion	$0	ExclusionAmt

Royalties Revenue RoyaltiesRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt
Related Or Exempt Func Income	$0	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$0	UnrelatedBusinessRevenueAmt
Exclusion	$0	ExclusionAmt

Gross Rents GrossRentsGrp

Field	Value	IRS element (for citing)
Real	$638,635	RealAmt
Personal	$0	PersonalAmt

Less Rental Expenses LessRentalExpensesGrp

Field	Value	IRS element (for citing)
Real	$2,178,864	RealAmt
Personal	$0	PersonalAmt

Rental Income Or Loss RentalIncomeOrLossGrp

Field	Value	IRS element (for citing)
Real	-$1,540,229	RealAmt
Personal	$0	PersonalAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

Field	Value	IRS element (for citing)
Total Revenue Column	-$1,540,229	TotalRevenueColumnAmt
Related Or Exempt Func Income	-$1,540,229	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$0	UnrelatedBusinessRevenueAmt
Exclusion	$0	ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

Field	Value	IRS element (for citing)
Securities	$0	SecuritiesAmt
Other	$0	OtherAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

Field	Value	IRS element (for citing)
Securities	$0	SecuritiesAmt
Other	$0	OtherAmt

Gain Or Loss GainOrLossGrp

Field	Value	IRS element (for citing)
Securities	$0	SecuritiesAmt
Other	$0	OtherAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt
Related Or Exempt Func Income	$0	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$0	UnrelatedBusinessRevenueAmt
Exclusion	$0	ExclusionAmt

Field	Value	IRS element (for citing)
Fundraising Gross Income	$0	FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event	$0	ContriRptFundraisingEventAmt
Fundraising Direct Expenses	$0	FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt
Unrelated Business Revenue	$0	UnrelatedBusinessRevenueAmt
Exclusion	$0	ExclusionAmt

Field	Value	IRS element (for citing)
Gaming Gross Income	$0	GamingGrossIncomeAmt
Gaming Direct Expenses	$0	GamingDirectExpensesAmt

Net Income From Gaming NetIncomeFromGamingGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt
Related Or Exempt Func Income	$0	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$0	UnrelatedBusinessRevenueAmt
Exclusion	$0	ExclusionAmt

Field	Value	IRS element (for citing)
Gross Sales Of Inventory	$0	GrossSalesOfInventoryAmt
Cost Of Goods Sold	$0	CostOfGoodsSoldAmt

Net Income Or Loss NetIncomeOrLossGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt
Related Or Exempt Func Income	$0	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$0	UnrelatedBusinessRevenueAmt
Exclusion	$0	ExclusionAmt

Miscellaneous Revenue MiscellaneousRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$195,055	TotalRevenueColumnAmt
Related Or Exempt Func Income	$195,055	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$0	UnrelatedBusinessRevenueAmt
Exclusion	$0	ExclusionAmt

Field	Value	IRS element (for citing)
Other Revenue Total	$195,055	OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$81,653,857	TotalRevenueColumnAmt
Related Or Exempt Func Income	-$448,395	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$0	UnrelatedBusinessRevenueAmt
Exclusion	$0	ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

Field	Value	IRS element (for citing)
Total	$2,526,668	TotalAmt
Program Services	$2,526,668	ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt
Program Services	$0	ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

Field	Value	IRS element (for citing)
Total	$8,971,642	TotalAmt
Program Services	$8,971,642	ProgramServicesAmt

Benefits To Members BenefitsToMembersGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt
Program Services	$0	ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

Field	Value	IRS element (for citing)
Total	$2,656,246	TotalAmt
Program Services	$1,213,686	ProgramServicesAmt
Management And General	$1,442,560	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Comp Disqual Persons CompDisqualPersonsGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt
Program Services	$0	ProgramServicesAmt
Management And General	$0	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

Field	Value	IRS element (for citing)
Total	$16,630,976	TotalAmt
Program Services	$13,203,946	ProgramServicesAmt
Management And General	$3,425,457	ManagementAndGeneralAmt
Fundraising	$1,573	FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

Field	Value	IRS element (for citing)
Total	$1,171,433	TotalAmt
Program Services	$853,755	ProgramServicesAmt
Management And General	$317,573	ManagementAndGeneralAmt
Fundraising	$105	FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

Field	Value	IRS element (for citing)
Total	$2,405,673	TotalAmt
Program Services	$1,909,952	ProgramServicesAmt
Management And General	$495,493	ManagementAndGeneralAmt
Fundraising	$228	FundraisingAmt

Payroll Taxes PayrollTaxesGrp

Field	Value	IRS element (for citing)
Total	$1,162,222	TotalAmt
Program Services	$910,027	ProgramServicesAmt
Management And General	$252,087	ManagementAndGeneralAmt
Fundraising	$108	FundraisingAmt

Fees For Services Management FeesForServicesManagementGrp

Field	Value	IRS element (for citing)
Total	$29,036,765	TotalAmt
Program Services	$28,147,663	ProgramServicesAmt
Management And General	$873,081	ManagementAndGeneralAmt
Fundraising	$16,021	FundraisingAmt

Fees For Services Legal FeesForServicesLegalGrp

Field	Value	IRS element (for citing)
Total	$44,245	TotalAmt
Program Services	$17,464	ProgramServicesAmt
Management And General	$26,781	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Fees For Services Accounting FeesForServicesAccountingGrp

Field	Value	IRS element (for citing)
Total	$535,619	TotalAmt
Program Services	$5,735	ProgramServicesAmt
Management And General	$529,884	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt
Program Services	$0	ProgramServicesAmt
Management And General	$0	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

Field	Value	IRS element (for citing)
Total	$0	TotalAmt
Fundraising	$0	FundraisingAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

Field	Value	IRS element (for citing)
Total	$54,461	TotalAmt
Program Services	$14,872	ProgramServicesAmt
Management And General	$39,589	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Fees For Services Other FeesForServicesOtherGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt
Program Services	$0	ProgramServicesAmt
Management And General	$0	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Advertising AdvertisingGrp

Field	Value	IRS element (for citing)
Total	$258,421	TotalAmt
Program Services	$186,963	ProgramServicesAmt
Management And General	$71,458	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Office Expenses OfficeExpensesGrp

Field	Value	IRS element (for citing)
Total	$853,385	TotalAmt
Program Services	$653,921	ProgramServicesAmt
Management And General	$199,464	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Information Technology InformationTechnologyGrp

Field	Value	IRS element (for citing)
Total	$1,014,659	TotalAmt
Program Services	$639,547	ProgramServicesAmt
Management And General	$375,112	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Royalties RoyaltiesGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt
Program Services	$0	ProgramServicesAmt
Management And General	$0	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Occupancy OccupancyGrp

Field	Value	IRS element (for citing)
Total	$523,505	TotalAmt
Program Services	$34,925	ProgramServicesAmt
Management And General	$488,580	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Travel TravelGrp

Field	Value	IRS element (for citing)
Total	$1,524,332	TotalAmt
Program Services	$1,489,736	ProgramServicesAmt
Management And General	$34,596	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt
Program Services	$0	ProgramServicesAmt
Management And General	$0	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Conferences Meetings ConferencesMeetingsGrp

Field	Value	IRS element (for citing)
Total	$492,405	TotalAmt
Program Services	$406,234	ProgramServicesAmt
Management And General	$85,895	ManagementAndGeneralAmt
Fundraising	$276	FundraisingAmt

Interest InterestGrp

Field	Value	IRS element (for citing)
Total	$290,126	TotalAmt
Program Services	$0	ProgramServicesAmt
Management And General	$290,126	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Payments To Affiliates PaymentsToAffiliatesGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt
Program Services	$0	ProgramServicesAmt
Management And General	$0	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Depreciation Depletion DepreciationDepletionGrp

Field	Value	IRS element (for citing)
Total	$1,357,835	TotalAmt
Program Services	$0	ProgramServicesAmt
Management And General	$1,357,835	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Insurance InsuranceGrp

Field	Value	IRS element (for citing)
Total	$190,221	TotalAmt
Program Services	$46,792	ProgramServicesAmt
Management And General	$143,429	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDesc	TotalTotalAmt	Program ServicesProgramServicesAmt	Management And GeneralManagementAndGeneralAmt	FundraisingFundraisingAmt
Bank Charges/Swap Interest	$36,251	$34,993	$1,136	$122
Miscellaneous	$54,970	$32,200	$22,701	$69
Dues and Subscription	$137,112	$66,691	$67,274	$3,147
Other Direct Program Expense	$2,646,439	$2,627,377	$19,062	$0

All Other Expenses AllOtherExpensesGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Total Functional Expenses TotalFunctionalExpensesGrp

Field	Value	IRS element (for citing)
Total	$74,575,611	TotalAmt
Program Services	$63,994,789	ProgramServicesAmt
Management And General	$10,559,173	ManagementAndGeneralAmt
Fundraising	$21,649	FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

Field	Value	IRS element (for citing)
BOY	$26,666,556	BOYAmt
EOY	$36,238,598	EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$3,766,415	BOYAmt
EOY	$4,141,520	EOYAmt

Accounts Receivable AccountsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

Field	Value	IRS element (for citing)
BOY	$2,357,836	BOYAmt
EOY	$1,940,179	EOYAmt

Field	Value	IRS element (for citing)
Land Bldg Equip Cost Or Other Bss	$31,643,040	LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec	$8,097,674	LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

Field	Value	IRS element (for citing)
BOY	$24,903,202	BOYAmt
EOY	$23,545,366	EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

Field	Value	IRS element (for citing)
BOY	$10,267,560	BOYAmt
EOY	$10,575,386	EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Intangible Assets IntangibleAssetsGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Other Assets Total OtherAssetsTotalGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Total Assets TotalAssetsGrp

Field	Value	IRS element (for citing)
BOY	$67,961,569	BOYAmt
EOY	$76,441,049	EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

Field	Value	IRS element (for citing)
BOY	$3,806,089	BOYAmt
EOY	$3,992,274	EOYAmt

Grants Payable GrantsPayableGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Deferred Revenue DeferredRevenueGrp

Field	Value	IRS element (for citing)
BOY	$1,982,212	BOYAmt
EOY	$1,628,643	EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$5,775,000	BOYAmt
EOY	$5,425,000	EOYAmt

Escrow Account Liability EscrowAccountLiabilityGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Other Liabilities OtherLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$3,801,588	BOYAmt
EOY	$5,720,206	EOYAmt

Total Liabilities TotalLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$15,364,889	BOYAmt
EOY	$16,766,123	EOYAmt

Field	Value	IRS element (for citing)
Organization Follows FASB117	Yes (X)	OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$27,164,362	BOYAmt
EOY	$29,014,379	EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$25,432,318	BOYAmt
EOY	$30,660,547	EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$52,596,680	BOYAmt
EOY	$59,674,926	EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$67,961,569	BOYAmt
EOY	$76,441,049	EOYAmt

Field	Value	IRS element (for citing)
Reconcilation Revenue Expnss	$7,078,246	ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst	$0	NetUnrlzdGainsLossesInvstAmt
Donated Services And Use Fclts	$0	DonatedServicesAndUseFcltsAmt
Investment Expense	$0	InvestmentExpenseAmt
Prior Period Adjustments	$0	PriorPeriodAdjustmentsAmt
Other Changes In Net Assets	$0	OtherChangesInNetAssetsAmt
Method Of Accounting Accrual	Yes (X)	MethodOfAccountingAccrualInd
Accountant Compile Or Review	0	AccountantCompileOrReviewInd
FS Audited	Yes (1)	FSAuditedInd
Audit Committee	Yes (1)	AuditCommitteeInd
Federal Grant Audit Required	Yes (1)	FederalGrantAuditRequiredInd
Federal Grant Audit Performed	Yes (1)	FederalGrantAuditPerformedInd

Schedule A IRS990ScheduleA

Field	Value	IRS element (for citing)
Public Organization170	Yes (X)	PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$68,115,208	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$36,813,330	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$47,166,232	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$45,641,975	CurrentTaxYearMinus1YearAmt
Current Tax Year	$66,108,782	CurrentTaxYearAmt
Total	$263,845,527	TotalAmt

Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$0	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$0	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$0	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$0	CurrentTaxYearMinus1YearAmt
Current Tax Year	$0	CurrentTaxYearAmt
Total	$0	TotalAmt

Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$0	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$0	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$0	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$0	CurrentTaxYearMinus1YearAmt
Current Tax Year	$0	CurrentTaxYearAmt
Total	$0	TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$68,115,208	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$36,813,330	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$47,166,232	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$45,641,975	CurrentTaxYearMinus1YearAmt
Current Tax Year	$66,108,782	CurrentTaxYearAmt
Total	$263,845,527	TotalAmt

Field	Value	IRS element (for citing)
Substantial Contributors Tot	$66,501,000	SubstantialContributorsTotAmt
Public Support Total170	$197,344,527	PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$89,763	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$825,669	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$1,189,041	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$1,412,850	CurrentTaxYearMinus1YearAmt
Current Tax Year	$1,499,153	CurrentTaxYearAmt
Total	$5,016,476	TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$0	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	-$222,353	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	-$598,040	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	-$457,765	CurrentTaxYearMinus1YearAmt
Current Tax Year	-$1,540,029	CurrentTaxYearAmt
Total	-$2,818,187	TotalAmt

Other Income170 OtherIncome170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$0	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$0	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$0	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$0	CurrentTaxYearMinus1YearAmt
Total	$0	TotalAmt

Field	Value	IRS element (for citing)
Total Support	$266,043,816	TotalSupportAmt
Gross Receipts Rltd Activities	$0	GrossReceiptsRltdActivitiesAmt
Public Support CY170	0.74177	PublicSupportCY170Pct
Public Support PY170	0.80054	PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170	Yes (X)	ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

Field	Value	IRS element (for citing)
Contributor	RESTRICTED	ContributorNum

Contributor Business Name ContributorBusinessName

Field	Value	IRS element (for citing)
Business Name Line1	RESTRICTED	BusinessNameLine1

Contributor US Address ContributorUSAddress

Field	Value	IRS element (for citing)
Address Line1	RESTRICTED	AddressLine1
Address Line2	RESTRICTED	AddressLine2
City	RESTRICTED	City
State	RESTRICTED	State
ZIP Code	RESTRICTED	ZIPCode

Field	Value	IRS element (for citing)
Total Contributions	RESTRICTED	TotalContributionsAmt

Schedule C IRS990ScheduleC

Field	Value	IRS element (for citing)
Volunteers	0	VolunteersInd
Paid Staff Or Management	Yes (1)	PaidStaffOrManagementInd
Media Advertisements	0	MediaAdvertisementsInd
Mailings Members	0	MailingsMembersInd
Publications Or Broadcast	0	PublicationsOrBroadcastInd
Grants Other Organizations	0	GrantsOtherOrganizationsInd
Direct Contact Legislators	Yes (1)	DirectContactLegislatorsInd
Direct Contact Legislators	$12,000	DirectContactLegislatorsAmt
Rallies Demonstrations	Yes (1)	RalliesDemonstrationsInd
Rallies Demonstrations	$9,269	RalliesDemonstrationsAmt
Other Activities	0	OtherActivitiesInd
Total Lobbying Expenditures	$21,269	TotalLobbyingExpendituresAmt
Not Described Section501c3	0	NotDescribedSection501c3Ind

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	Schedule C, Part II-B, Line 1	FormAndLineReferenceDesc
Explanation	Advocacy coalition participation and consultant expenses in support of global health programs.	ExplanationTxt

Schedule D IRS990ScheduleD

Land LandGrp

Field	Value	IRS element (for citing)
Investment Cost Or Other Basis	$0	InvestmentCostOrOtherBasisAmt
Other Cost Or Other Basis	$2,135,100	OtherCostOrOtherBasisAmt
Book Value	$2,135,100	BookValueAmt

Buildings BuildingsGrp

Field	Value	IRS element (for citing)
Investment Cost Or Other Basis	$0	InvestmentCostOrOtherBasisAmt
Other Cost Or Other Basis	$26,211,582	OtherCostOrOtherBasisAmt
Depreciation	$5,197,270	DepreciationAmt
Book Value	$21,014,312	BookValueAmt

Leasehold Improvements LeaseholdImprovementsGrp

Field	Value	IRS element (for citing)
Investment Cost Or Other Basis	$0	InvestmentCostOrOtherBasisAmt
Other Cost Or Other Basis	$0	OtherCostOrOtherBasisAmt
Depreciation	$0	DepreciationAmt
Book Value	$0	BookValueAmt

Equipment EquipmentGrp

Field	Value	IRS element (for citing)
Investment Cost Or Other Basis	$0	InvestmentCostOrOtherBasisAmt
Other Cost Or Other Basis	$1,456,619	OtherCostOrOtherBasisAmt
Depreciation	$1,456,619	DepreciationAmt
Book Value	$0	BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

Field	Value	IRS element (for citing)
Investment Cost Or Other Basis	$0	InvestmentCostOrOtherBasisAmt
Other Cost Or Other Basis	$1,839,739	OtherCostOrOtherBasisAmt
Depreciation	$1,443,785	DepreciationAmt
Book Value	$395,954	BookValueAmt

Field	Value	IRS element (for citing)
Total Book Value Land Buildings	$23,545,366	TotalBookValueLandBuildingsAmt
Federal Income Tax Liability	$0	FederalIncomeTaxLiabilityAmt

Other Liabilities Org OtherLiabilitiesOrgGrp (4 entries)

DescDesc	AmtAmt
Interest Rate Swap Liability	$301,805
Accrued Absences	$456,510
Payroll Liabilities	$4,016,946
Other Accrued Liabilities	$944,945

Field	Value	IRS element (for citing)
Total Liability	$5,720,206	TotalLiabilityAmt
Total Rev Etc Audited Fincl Stmt	$81,458,802	TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst	$0	NetUnrealizedGainsInvstAmt
Donated Services And Use Fclts	$0	DonatedServicesAndUseFcltsAmt
Recoveries Prior Year Grants	$0	RecoveriesPriorYearGrantsAmt
Other Revenue	$0	OtherRevenueAmt
Revenue Not Reported	$0	RevenueNotReportedAmt
Revenue Subtotal	$81,458,802	RevenueSubtotalAmt
Investment Expenses Not Incld	$0	InvestmentExpensesNotIncldAmt
Other Revenues Not Included	$195,055	OtherRevenuesNotIncludedAmt
Revenue Not Reported Fincl Stmt	$195,055	RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990	$81,653,857	TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt	$74,575,611	TotExpnsEtcAuditedFinclStmtAmt
Donated Services Use Fclts	$0	DonatedServicesUseFcltsAmt
Prior Year Adjustments	$0	PriorYearAdjustmentsAmt
Losses Reported	$0	LossesReportedAmt
Other Expenses Included	$0	OtherExpensesIncludedAmt
Expenses Not Reported	$0	ExpensesNotReportedAmt
Expenses Subtotal	$74,575,611	ExpensesSubtotalAmt
Investment Expenses Not Incld2	$0	InvestmentExpensesNotIncld2Amt
Other Expenses Not Included	$0	OtherExpensesNotIncludedAmt
Expenses Not Rpt Fincl Stmt	$0	ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990	$74,575,611	TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	Schedule D, Part XI, Line 4b	FormAndLineReferenceDesc
Explanation	Amount represents Interest Rate Swap revenue.	ExplanationTxt

Schedule F IRS990ScheduleF

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (1)	GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (7 entries)

RegionRegionTxt	OfficesOfficesCnt	EmployeeEmployeeCnt	Type Of Activities ConductedTypeOfActivitiesConductedTxt	Specific Services ProvidedSpecificServicesProvidedTxt	Region Total ExpendituresRegionTotalExpendituresAmt
Central America and the Caribbean	0	0	Program Services	Operational research to support neglected tropical diseases	$49,177
Middle East and North Africa	0	0	Program Services	Operational Research support.	$96,529
South America	0	0	Program Services	Health Campaign Effectiveness support	$103,393
East Asia and the Pacific	0	0	Program Services	Health Campaign Effectiveness and Operational Research support.	$137,864
Europe (including Iceland and Greenland)	0	0	Program Services	COVID Response support.	$1,225,818
South Asia	0	0	Program Services	Health Campaign Effectiveness, Operational Research and COVID Response support.	$2,480,120
Sub-Saharan Africa	1	12	Program Services	Health Campaign Effectiveness, Operational Research and COVID Response support.	$4,878,740

Field	Value	IRS element (for citing)
Total Office	1	TotalOfficeCnt
Total Employee	12	TotalEmployeeCnt
Total Spent	$8,971,641	TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (6 entries)

RegionRegionTxt	Purpose Of GrantPurposeOfGrantTxt	Cash GrantCashGrantAmt	Manner Of Cash DisbursementMannerOfCashDisbursementTxt	Non Cash AssistanceNonCashAssistanceAmt	Description Of Non Cash AsstDescriptionOfNonCashAsstTxt	Valuation Method UsedValuationMethodUsedDesc
Central America and the Caribbean	Operational Research support.	$49,177	Wire transfer	$0	N/A	N/A
South America	Health Campaign Effectiveness support.	$103,393	Wire transfer	$0	N/A	N/A
East Asia and the Pacific	Operational Research and COVID Response support.	$137,864	Wire transfer	$0	N/A	N/A
South Asia	Health Campaign Effectiveness, Operational Research and COVID Response support.	$2,480,120	Wire transfer	$0	N/A	N/A
Sub-Saharan Africa	Health Campaign Effectiveness, Operational Research, Oncho and COVID Response support.	$4,878,740	Wire transfer	$0	N/A	N/A
Middle East and North Africa	Operational Research support.	$96,529	Wire transfer	$0	N/A	N/A

Field	Value	IRS element (for citing)
Total501c3 Org	9	Total501c3OrgCnt
Total Other Org	52	TotalOtherOrgCnt
Transfer To Foreign Corp	0	TransferToForeignCorpInd
Interest In Foreign Trust	0	InterestInForeignTrustInd
Foreign Corp Ownership	0	ForeignCorpOwnershipInd
Passive Foreign Investmest Co	0	PassiveForeignInvestmestCoInd
Foreign Partnership	0	ForeignPartnershipInd
Boycott Countries	0	BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	Schedule F, Part I, Line 2	FormAndLineReferenceDesc
Explanation	A Contract is executed with all the required deliverables and budget. Based on work performance, an agreed percentage of the grant is paid to the recipient after receiving an invoice and a narrative report. Occasionally, there are visits to the countries for feedback and to assess the impact of the project. Budget over-runs have to be explained before a contract amendment, if necessary, is made.	ExplanationTxt

Schedule I IRS990ScheduleI

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (1)	GrantRecordsMaintainedInd

Recipient Table RecipientTable (4 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	Recipient EINRecipientEIN	Cash GrantCashGrantAmt	Non Cash AssistanceNonCashAssistanceAmt	Valuation Method UsedValuationMethodUsedDesc	Non Cash AssistanceNonCashAssistanceDesc	Purpose Of GrantPurposeOfGrantTxt
Meritus Advisory Group LLC
6200 E Shallowford Ct	Suffolk	VA	23435	464132399	$18,550	$0	N/A	N/A	Support for COVID-19
The Regents of the University of California
2195 Hearst Ave RM 130 MC 1103	Berkeley	CA	94720	943067788	$39,654	$0	N/A	N/A	Support for COVID-19
Georgetown University
4000 Reservoir Rd NW Bldg D Ste	Washington	DC	20057	530196603	$48,831	$0	N/A	N/A	Support for COVID-19
Center for Global Health Innovation
999 Peachtree Street NE	Atlanta	GA	30309	581849665	$2,419,633	$0	N/A	N/A	Support for COVID-19

Field	Value	IRS element (for citing)
Total501c3 Org	3	Total501c3OrgCnt
Total Other Org	1	TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	Schedule I, Part I, Line 2	FormAndLineReferenceDesc
Explanation	Project managers monitor the activities and deliverables on the contracts by tracking deliverables in Smartsheet and ensuring the deliverables are completed on time by notifying the sub-awardees of deliverable due dates at least 3 days in advance. We request at least 2 financial reports throughout the duration of the project to monitor expenditures and we only send approximately 40% of the funds upfront depending on the size and duration of the award. We also monitor progress by attending monthly calls. If there are any delays or risks to completing the project on time, we work with the sub-awardee to make sure we have updated timelines and work with our grantor to make sure we follow the appropriate no-cost extension timelines to extend sub-awards when needed.	ExplanationTxt

Schedule J IRS990ScheduleJ

Field	Value	IRS element (for citing)
Compensation Committee	Yes (X)	CompensationCommitteeInd
Compensation Survey	Yes (X)	CompensationSurveyInd
Board Or Committee Approval	Yes (X)	BoardOrCommitteeApprovalInd
Severance Payment	Yes (1)	SeverancePaymentInd
Supplemental Nonqual Rtr Plan	0	SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm	0	EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org	0	CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs	0	CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org	0	CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs	0	CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments	0	AnyNonFixedPaymentsInd
Initial Contract Exception	0	InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (15 entries)

TitleTitleTxt	Base Compensation Filing OrgBaseCompensationFilingOrgAmt	Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt	Bonus Filing OrganizationBonusFilingOrganizationAmount	Bonus Related OrganizationsBonusRelatedOrganizationsAmt	Other Compensation Filing OrgOtherCompensationFilingOrgAmt	Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt	Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt	Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt	Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt	Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt	Total Compensation Filing OrgTotalCompensationFilingOrgAmt	Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt	Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt	Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
David A Ross
President & CEO	$382,486	$0	$0	$0	$0	$0	$22,267	$0	$30,844	$0	$435,597	$0	$0	$0
Mark McKinlay
Program Director	$272,907	$0	$0	$0	$0	$0	$25,011	$0	$30,741	$0	$328,659	$0	$0	$0
William P Nichols
Exec. VP/COO	$270,492	$0	$21,277	$0	$0	$0	$24,335	$0	$1,192	$0	$317,296	$0	$0	$0
Heather Brooks
Director of Organizational Effectiveness	$77,079	$0	$0	$0	$0	$0	$6,937	$0	$14,067	$0	$98,083	$0	$0	$0
Ellen Wild
Director of Business Strategy	$172,266	$0	$11,413	$0	$0	$0	$15,596	$0	$1,028	$0	$200,303	$0	$0	$0
Daniel Martins
Chief Financial Officer	$145,637	$0	$6,300	$0	$2,601	$0	$14,193	$0	$44,731	$0	$213,462	$0	$0	$0
Patrick O'Carroll
Program Sector Head	$286,647	$0	$0	$0	$0	$0	$25,650	$0	$1,419	$0	$313,716	$0	$0	$0
Patrick Lammie
Program Director	$228,276	$0	$0	$0	$0	$0	$20,534	$0	$1,013	$0	$249,823	$0	$0	$0
Vivian Singletary
Program Director	$225,131	$0	$0	$0	$0	$0	$17,666	$0	$27,373	$0	$270,170	$0	$0	$0
John Ward
Program Director	$259,316	$0	$0	$0	$0	$0	$20,736	$0	$480	$0	$280,532	$0	$0	$0
David G Addis
Program Director	$246,487	$0	$0	$0	$2,000	$0	$21,853	$0	$30,636	$0	$300,976	$0	$0	$0
Kris Sarlas
Program Director	$197,547	$0	$0	$0	$0	$0	$14,918	$0	$41,592	$0	$254,057	$0	$0	$0
Paul Emerson
Program Director	$238,908	$0	$0	$0	$0	$0	$22,468	$0	$45,183	$0	$306,559	$0	$0	$0
Yao Sodahlon
Program Director	$231,580	$0	$0	$0	$0	$0	$20,793	$0	$42,335	$0	$294,708	$0	$0	$0
Carl Reddy
Program Director	$214,444	$0	$0	$0	$0	$0	$19,868	$0	$44,286	$0	$278,598	$0	$0	$0

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	Schedule J, Part I, Line 4	FormAndLineReferenceDesc
Explanation	There was a separation payment of $98,083 for Heather Brooks.	ExplanationTxt

Schedule K IRS990ScheduleK

Tax Exempt Bonds Issues TaxExemptBondsIssuesGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd

Issuer Name IssuerName

Field	Value	IRS element (for citing)
Business Name Line1	Development Authority of DeKalb County	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Bond Issuer EIN	581500666	BondIssuerEIN
CUSIP	000000000	CUSIPNum
Bond Issued	2016-12-15	BondIssuedDt
Issue Price	$7,000,000	IssuePriceAmt
Purpose	Finance the purchase of a building	PurposeDesc
Defeased	0	DefeasedInd
On Behalf Of Issuer	0	OnBehalfOfIssuerInd
Pool Financing	0	PoolFinancingInd

Tax Exempt Bonds Proceeds TaxExemptBondsProceedsGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd
Retired	$1,575,000	RetiredAmt
Bond Defeased	$0	BondDefeasedAmt
Total Proceeds	$7,000,000	TotalProceedsAmt
In Reserve Fund	$0	InReserveFundAmt
Capitalized Interest	$0	CapitalizedInterestAmt
Refunding Escrow	$0	RefundingEscrowAmt
Issuance Costs From Proceeds	$0	IssuanceCostsFromProceedsAmt
Credit Enhancement	$0	CreditEnhancementAmt
Working Capital Expenditures	$0	WorkingCapitalExpendituresAmt
Capital Expenditures	$7,000,000	CapitalExpendituresAmt
Other Spent Proceeds	$0	OtherSpentProceedsAmt
Unspent	$0	UnspentAmt
Substantial Completion	2018	SubstantialCompletionYr
Refunding Tax Exempt Bonds	0	RefundingTaxExemptBondsInd
Refunding Taxable Bonds	0	RefundingTaxableBondsInd
Final Allocation Made	Yes (1)	FinalAllocationMadeInd
Adequate Books And Rec Maint	Yes (1)	AdequateBooksAndRecMaintInd

Tax Exempt Bonds Private Bus Use TaxExemptBondsPrivateBusUseGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd
Owning Bond Financed Property	0	OwningBondFinancedPropertyInd
Any Lease Arrangements	0	AnyLeaseArrangementsInd
Mgmt Contract Bond Fincd Prop	0	MgmtContractBondFincdPropInd
Any Research Agreements	0	AnyResearchAgreementsInd
Private Bus Use By Others	0	PrivateBusUseByOthersPct
Private Bus Concerning UBI	0	PrivateBusConcerningUBIPct
Total Private Business Use	0	TotalPrivateBusinessUsePct
Bond Iss Meet Prvt Sec Pymt Test	Yes (1)	BondIssMeetPrvtSecPymtTestInd
Change In Use Bond Financed Prop	0	ChangeInUseBondFinancedPropInd
Procs Nonqualified Bond Remdtd	0	ProcsNonqualifiedBondRemdtdInd

Tax Exempt Bonds Arbitrage TaxExemptBondsArbitrageGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd
Form8038 T Filed	0	Form8038TFiledInd
Rebate Not Due Yet	0	RebateNotDueYetInd
Exception To Rebate	0	ExceptionToRebateInd
No Rebate Due	0	NoRebateDueInd
Variable Rate Issue	Yes (1)	VariableRateIssueInd
Hedge Identified In Bks And Rec	Yes (1)	HedgeIdentifiedInBksAndRecInd

Hedge Provider Name HedgeProviderName

Field	Value	IRS element (for citing)
Business Name Line1	Truist Bank (formerly Sun Trust Bank)	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Term Of Hedge	16.9	TermOfHedgePct
Superintegrated Hedge	0	SuperintegratedHedgeInd
Hedge Terminated	0	HedgeTerminatedInd
Gross Proceeds Invested In GIC	0	GrossProceedsInvestedInGICInd
Gross Proceeds Invested	0	GrossProceedsInvestedInd
Written Proc To Monitor Reqs	0	WrittenProcToMonitorReqsInd

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (4 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
Form 990, Part VI, Section B, Line 11b	Once the Return is prepared by the CFO, it is reviewed by management and thereafter made available to all board members for any comments, clarifications or corrections. After the board's review, the Return is finalized and filed with the IRS.
Form 990, Part VI, Section B, Line 12c	Board members, officers, and all employees are required to annually sign a declaration that they have read, and have complied with, the Conflict of Interest Policy. Any suspected or reported violations of the policy are to be referred to the Exec. VP/COO who would follow-up and investigate the matter.
Form 990, Part VI, Section B, Line 15	The Task Force for Global Health, Inc. is an affiliate of Emory University and as such, all its employees are in fact Emory employees. For both the President and Exec. VP/COO, Emory includes these positions in its annual market review of compensated professionals in these categories. In addition, performance is measured against SMART goals. Furthermore the board reviews performance including a 360 feedback loop finalizing the President's performance.
Form 990, Part VI, Section C, Line 19	Three years of audited financial statements and 990 Tax Returns are posted on the organization's website together with the Conflict of Interest policy and governing documents - Bylaws.

Schedule R IRS990ScheduleR

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp

Disregarded Entity Name DisregardedEntityName

Field	Value	IRS element (for citing)
Business Name Line1	Global Health Solutions Inc	BusinessNameLine1Txt

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	330 W Ponce de Leon Ave	AddressLine1Txt
City	Decatur	CityNm
State Abbreviation	GA	StateAbbreviationCd
ZIP	30030	ZIPCd

Field	Value	IRS element (for citing)
EIN	203674498	EIN
Primary Activities	Oversees donated pharmaceutical products	PrimaryActivitiesTxt
Legal Domicile State	GA	LegalDomicileStateCd
Exempt Code Section	501 (c)(3)	ExemptCodeSectionTxt
Public Charity Status	509(a)(3) Type 1	PublicCharityStatusTxt

Direct Controlling Entity Name DirectControllingEntityName

Field	Value	IRS element (for citing)
Business Name Line1	None	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Controlled Organization	0	ControlledOrganizationInd

Field	Value	IRS element (for citing)
Receipt Of Int Annts Rnts Rylts	0	ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth Org	0	GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth Org	0	GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other Org	0	LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org	0	LoansOrGuaranteesFromOthOrgInd
Div Related Organization	0	DivRelatedOrganizationInd
Asset Sale To Other Org	0	AssetSaleToOtherOrgInd
Asset Purchase From Other Org	0	AssetPurchaseFromOtherOrgInd
Asset Exchange	0	AssetExchangeInd
Rental Of Facilities To Oth Org	0	RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org	0	RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org	0	PerformOfServicesForOthOrgInd
Perform Of Services By Other Org	0	PerformOfServicesByOtherOrgInd
Sharing Of Facilities	0	SharingOfFacilitiesInd
Paid Employees Sharing	Yes (1)	PaidEmployeesSharingInd
Reimbursement Paid To Other Org	0	ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other Org	0	ReimbursementPaidByOtherOrgInd
Transfer To Other Org	0	TransferToOtherOrgInd
Transfer From Other Org	0	TransferFromOtherOrgInd

Reasonable Cause Explanation ReasonableCauseExplanation

Field	Value	IRS element (for citing)
Explanation	There is no doubt that human life and activities have been reshaped by the COVID-19 pandemic in the past two years and may continue beyond that. As a company, we also felt the COVID-19 impact in many ways. In November/December 2021, we had to separate two accounting staff due to a new corporate policy. One of these two played a major role in information gathering for the filing of the Form 990. In her absence, a vacuum was created which took some time to fill. Additionally, one of our Programs is actively involved with the Centers for Disease Control and Prevention in the fight against COVID-19. We were therefore swarmed with a lot of requests to send funds to many countries all around the world. Given the increased volume of work and reduced staffing, the daily tasks became overwhelming on the existing staff who had to deal with personal challenges at home, as well. In the midst of all these circumstances, we were not able to file for the required extension. Historically, we have never filed a late return, but as one may attest, the past few years have been nothing like normal. Humbly, we request that you make an exception to this late filing and waive any fees that may have accrued.	ExplanationTxt